Mammoth Biosciences
PrivateLast Round
Series D
Sep 9, 2021
Est. Valuation
$1B
Total Funding Raised
$287.6M
Company Overview
Mammoth Biosciences is a biotechnology company that develops long-term curative therapies and decentralized precision diagnostics using proprietary ultracompact CRISPR proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mammoth Biosciences Comparables
Compare Mammoth Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Metagenomi | 85% | |
| Arbor Biotechnologies | 82% | |
| Scribe Therapeutics | 77% | |
Mammoth Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 9, 2021 | ||||
| Series C | Nov 1, 2020 | ||||
| Grant | Jul 30, 2020 | ||||
| Series B | Jan 30, 2020 | ||||
| Series A | Jul 31, 2018 | ||||
Seed | Nov 1, 2017 |
Key People
Founding team and executive leadership
Mammoth Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series C, Series D |
| NFX | Series A, Series B, Series D, Seed, Pre Seed |
| Pacific 8 Ventures | Series B |
| NIH RADx | Grant |
| Plum Alley Investments | Series B |
| StepStone Group | Series D |
| Sixth Street Partners | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Preclinical data for MB-111 to be presented at industry congress.
- Oct 1, 2025
Presenting at the European Society of Gene & Cell Therapy Congress.
Mammoth Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mammoth Biosciences's valuation, stock price, and market status.